Who owns Sensei Biotherapeutics Inc?
- Ticker: FTH
- CUSIP Number: 81728a207
Tip: Access positions for across all investors
Analyze quarterly positions in Sensei Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sensei Biotherapeutics stock
Who bought or sold Sensei Biotherapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Suvretta Capital Management | 2.0M | $51M | 5747% | Jun 2026 |
|
| venBio Select Advisor | 1.4M | $36M | 100% | Jun 2026 |
|
| Baker Bros. Advisors | 1.3M | $32M | 100% | Jun 2026 |
|
| Balyasny Asset Management | 1.0M | $26M | 6331% | Jun 2026 |
|
| Cormorant Asset Management | 1.0M | $7.7M | 236% | Jun 2026 |
|
| RA Capital Management | 722k | $18M | 100% | Jun 2026 |
|
| Vivo Capital | 722k | $18M | 0% | Jun 2026 |
|
| Fairmount Funds Management | 722k | $18M | 100% | Jun 2026 |
|
| Logos Global Management | 722k | $18M | 2307% | Jun 2026 |
|
| Caligan Partners | 630k | $16M | 400% | Jun 2026 |
|
| Trails Edge Capital Partners | 515k | $13M | 312% | Jun 2026 |
|
| Franklin Resources | 495k | $12M | 270% | Jun 2026 |
|
| Octagon Capital Advisors | 361k | $9.0M | 100% | Jun 2026 |
|
| ADAR1 Capital Management | 361k | $9.0M | 100% | Jun 2026 |
|
| Marshall Wace | 207k | $5.2M | 214% | Jun 2026 |
|
| Boxer Capital Management | 181k | $4.5M | 100% | Jun 2026 |
|
| Patient Square Capital | 175k | $4.4M | 100% | Jun 2026 |
|
| Alyeska Investment Group | 144k | $3.6M | 100% | Jun 2026 |
|
| Affinity Asset Advisors | 144k | $3.6M | 100% | Jun 2026 |
|
| Boothbay Fund Management | 134k | $3.3M | 412% | Jun 2026 |
|
| AWM Investment Company | 111k | $2.8M | 100% | Jun 2026 |
|
| Richmond Investment Services | 80k | $2.0M | 100% | Jun 2026 |
|
| Ikarian Capital | 35k | $885k | 457% | Jun 2026 |
|
| UBS Group | 22k | $539k | 376% | Jun 2026 |
|
| Renaissance Technologies | 20k | $510k | -36% | Jun 2026 |
|
| Jane Street | 20k | $503k | 127% | Jun 2026 |
|
| Catalio Capital Management | 15k | $368k | 0% | Jun 2026 |
|
| Geode Capital Management | 15k | $365k | 54% | Jun 2026 |
|
| Superstring Capital Management | 14k | $354k | 100% | Jun 2026 |
|
| Barclays | 12k | $310k | 100% | Jun 2026 |
|
| Citadel Advisors | 12k | $307k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 10k | $253k | 31% | Jun 2026 |
|
| XTX Topco | 9.6k | $240k | 100% | Jun 2026 |
|
| Morgan Stanley | 8.8k | $277k | 87850% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 6.3k | $158k | 0% | Jun 2026 |
|
| China Universal Asset Management | 3.6k | $90k | 100% | Jun 2026 |
|
| BlackRock | 3.4k | $85k | 100% | Jun 2026 |
|
| Tower Research Capital | 650.00 | $16k | -57% | Jun 2026 |
|
| Royal Bank of Canada | 509.00 | $13k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 113.00 | $2.8k | 1156% | Jun 2026 |
|
| Jpmorgan Chase & Co | 40.00 | $930.000000 | 100% | Jun 2026 |
|
| Quarry | 32.00 | $800.000000 | 100% | Jun 2026 |
|
| UMA Financial Services | 28.00 | $700.000000 | 100% | Jun 2026 |
|
| SBI Securities | 4.00 | $100.000000 | 0% | Jun 2026 |
|
Who sold out of Sensei Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Mar 2026 | 147k | $4.6M |
| Stempoint Capital | Mar 2026 | 133k | $4.2M |
| Goldman Sachs Group | Mar 2026 | 62k | $1.9M |
| Hrt Financial | Mar 2026 | 58k | $1.8M |
| Bank of America Corporation | Mar 2026 | 33k | $1.0M |
| Brevan Howard Capital Management | Mar 2026 | 20k | $641k |
| Fred Alger Management | Mar 2026 | 18k | $578k |